Risk-Centric GenAI: A Financial Services Implementation Playbook

The Problem: Why This Matters Now

Your institution is receiving GenAI proposals from every business line. Marketing wants customer communication tools. Wealth management wants portfolio summarization. Operations wants document processing. Each pitch promises efficiency gains, but none addresses the fundamental question: how do you deploy these systems without creating unmanageable model risk?

Financial institutions operate under SR 11-7, which requires rigorous model validation, ongoing monitoring, and clear accountability for model risk. Generative AI doesn't fit the traditional model risk framework cleanly. These systems exhibit emergent behavior, produce non-deterministic outputs, and often rely on Foundation Model Providers whose training data and architecture remain opaque. Deploy without a risk-centric process and you're building technical debt that will surface during your next regulatory examination.

What You Need Before Starting

Before you approve a single GenAI deployment, establish these baseline capabilities:

Governance infrastructure:

• A designated AI governance committee with authority to approve or reject use cases
• Clear escalation paths for high-risk applications
• Documentation templates that capture GenAI-specific risks, such as hallucination potential and prompt injection vulnerabilities

Risk assessment framework:

• Risk Tiering criteria adapted from the NIST AI RMF that account for output determinism, human oversight requirements, and consequence severity
• A decision tree that routes use cases to appropriate validation rigor
• Vendor Due Diligence questionnaires that address Foundation Model Provider transparency, including training data governance and model limitations

Technical prerequisites:

• Logging infrastructure that captures prompts, outputs, and user feedback at the interaction level
• Access controls that prevent unauthorized model access or API key sharing
• A Feature Store or equivalent system for managing structured data inputs to GenAI systems

Legal and compliance alignment:

• Review of GDPR obligations if processing EU personal data
• Assessment of whether your use case triggers EU AI Act high-risk classifications
• Responsible Disclosure process for identified vulnerabilities

Step-by-Step Implementation

Phase 1: Intake and Initial Risk Tiering (Week 1)

When a business unit submits a GenAI proposal, route it through a structured intake:

1. Document the use case using a System Card template that captures:

   • Business objective and success metrics
   • Data inputs and user population
   • Output type and downstream consumption

2. Apply Risk Tiering:

   • Tier 1 (Low): Internal productivity tools with human review of all outputs, no customer PII, no financial decisions.
   • Tier 2 (Moderate): Customer-facing applications with human oversight, limited decision authority, or processing of non-sensitive data.
   • Tier 3 (High): Systems that influence credit, compliance, or regulatory reporting; process sensitive personal data; or operate with minimal human oversight.

3. Assign validation requirements based on tier. Tier 3 use cases require full SR 11-7 validation, including independent model review and bias testing.

Phase 2: Vendor and Model Selection (Weeks 2-3)

For each approved use case:

1. Conduct Vendor Due Diligence on the Foundation Model Provider:

   • Request Technical Documentation covering training data sources and bias mitigation approaches
   • Verify the provider's Post-Market Monitoring practices
   • Confirm contractual terms around data retention and model updates

2. Evaluate model fit:

   • Test prompt engineering approaches against representative scenarios
   • Assess hallucination rates through targeted queries
   • Document Contextual Risk Factors specific to your deployment

3. Establish Model Provisioning procedures:

   • Configure Rate Limiting to prevent abuse or cost overruns
   • Implement prompt templates that constrain output format
   • Set up logging that captures sufficient detail for Root Cause Analysis if incidents occur

Phase 3: Validation and Testing (Weeks 4-6)

Execute validation proportional to risk tier:

For all tiers:

• Document Instructions for Use
• Conduct Adversarial Simulation
• Test edge cases and ambiguous inputs

For Tier 2 and 3:

• Perform Bias Mitigation analysis
• Validate Reproducibility
• Establish performance benchmarks

For Tier 3 only:

• Engage independent validators
• Document Validation Evidence
• Establish quantitative performance thresholds

Phase 4: Deployment with Controls (Week 7)

Deploy with layered controls:

1. Technical controls:

   • Human-in-the-loop review for Tier 2 and 3 outputs
   • Output filtering to catch obvious hallucinations
   • Version control for prompt templates and model configurations

2. Operational controls:

   • User training on model limitations
   • Clear escalation procedures for incorrect outputs
   • Incident response plan for model failures

3. Transparency controls:

   • Disclosure of AI Interaction to end users
   • Documentation of AI-Generated Content Labelling
   • Audit trail linking outputs to specific model versions

Validation: How to Verify It Works

Immediate checks (Day 1-7 post-deployment):

• Review 100% of outputs manually or a statistically significant sample
• Confirm logging captures all required fields
• Test that Rate Limiting triggers at expected thresholds
• Verify escalation procedures work when users report issues

30-day validation:

• Analyze output quality metrics
• Review security logs for attempted prompt injection
• Compare actual usage patterns to documented Instructions for Use
• Assess whether performance meets the benchmarks established during validation

Red flags requiring immediate action:

• Hallucination rate exceeds baseline
• User complaints about biased outputs
• Unauthorized access attempts
• Model provider announces material changes

Maintenance: Ongoing Tasks

Weekly:

• Review output quality dashboards
• Monitor cost and usage against budget
• Triage user-reported issues

Monthly:

• Update Risk Tiering assessment if use case scope changes
• Review Vendor Due Diligence for any provider updates
• Conduct targeted Adversarial Simulation

Quarterly:

• Perform Model Recalibration if performance drifts
• Update Model Limitations documentation
• Re-validate Bias Mitigation controls

Annually:

• Full revalidation for Tier 3 models
• Refresh Vendor Due Diligence
• Update governance policies based on regulatory changes

Trigger-based (as needed):

• Foundation Model Provider announces model updates: assess impact and revalidate
• Regulatory examination announced: prepare Validation Evidence
• Security incident or Responsible Disclosure: execute Root Cause Analysis
• Business requests scope expansion: return to Phase 1 intake process

This playbook gives you a repeatable process that satisfies regulatory expectations while enabling controlled GenAI adoption. The key is matching validation rigor to actual risk, not applying one-size-fits-all controls that either under-protect high-risk use cases or create bureaucratic friction for low-risk productivity tools.